Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-06-04

Clinical Trial Update: Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet [NA]

View source ↗

Summary

A clinical trial comparing split-dose polyethylene glycol with clear fluids versus split-dose PEG with a low-residue diet in colorectal cancer patients; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: University of Calgary | Conditions: Colorectal Cancer | NA | Status: UNKNOWN